Prosecution Insights
Last updated: April 19, 2026
Application No. 17/751,943

METHODS TO PRODUCE DEFINED, SPHERICAL, BIO-DEGRADABLE MACROPOROUS MICROCARRIER/HYDROGELS FOR CELLULAR AGRICULTURE

Final Rejection §103
Filed
May 24, 2022
Examiner
CRUM, MARY ABOU NADER
Art Unit
1657
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Innocent Meat GmbH
OA Round
6 (Final)
41%
Grant Probability
Moderate
7-8
OA Rounds
3y 6m
To Grant
99%
With Interview

Examiner Intelligence

Grants 41% of resolved cases
41%
Career Allow Rate
32 granted / 78 resolved
-19.0% vs TC avg
Strong +68% interview lift
Without
With
+68.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
42 currently pending
Career history
120
Total Applications
across all art units

Statute-Specific Performance

§101
7.7%
-32.3% vs TC avg
§103
38.6%
-1.4% vs TC avg
§102
10.8%
-29.2% vs TC avg
§112
23.7%
-16.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 78 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claims 1-25 and 33-37, and 39-41 are pending. Claims 1-19, 25 and 33-36 are withdrawn. Claims 20-24, 37, and 39-41 are examined. Response to Amendment Applicant amended claim 24 to replace “first” with “second”, and canceled claim 38. The rejection of claims 24 and 38 under 35 U.S.C. 112(b) is withdrawn in view of the amendment. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 20-21, 23-24, 37, and 39-41 remain rejected under 35 U.S.C. 103 as being unpatentable over in Zhang (Industrial & Engineering Chemistry Research 57.21 (2018): 7291-7300, hereinafter “Zhang”) in view of Ye (RSC advances 7.77 (2017): 48826-48834). Regarding claim 20, Zhang teaches a system for producing macroporous alginate beads via cryo-crosslinking under freezing conditions comprising a micro-tube housing an alginate solution (i.e., a micro-dispenser), a tube connected to the microtube on one end and the second end connected to a pump, a first beaker housing a cooled cross-linking reagent and a second beaker housing ethanol under freezing and the cooled cross-linking reagent and configured to receive the frozen drops from the first beaker (Figure 1 of Zhang reproduced below, para 2.3). Zhang teaches the alginate droplets are first generated by the microtube dripping, then these alginate drops are frozen to solid-state beads partially, and then they are cross-linked by the cryo-cross-linking induced by Ca2+ under the freezing conditions (page 7293 left column first para.). In order to address Applicant’s argument, Zhang’s Figure 1 is interpreted as teaching a first beaker that houses a cooled cross-linker solution (i.e., cooled liquid) and receives the drops from the micro-dispenser. The second beaker contains the first beaker and as such the second beaker contains all the contents of the first beaker including the cooled cross-linking reagent and the frozen cross-linked drops. [AltContent: textbox (Second beaker housing the first beaker and all its contents (i.e., second beaker housing a cooled cross-linking reagent configured to receive the frozen drops from the first beaker))][AltContent: textbox (First beaker housing a cooled cross-linker (i.e. cooled liquid) receiving dispensed droplets from the micro-dispenser to form frozen drops. the micro-dispenser that themix with cooled liquid to form frozen drops)][AltContent: arrow][AltContent: arrow] PNG media_image1.png 200 400 media_image1.png Greyscale Zhang does not teach the second end of the tube being affixed to a component that receives pressured air. However, Ye teaches an air-blast microfluidic nozzle to produce alginate microparticles comprising a microfluidic nozzle housing an alginate solution and a tube connected to the microfluidic nozzle on one end and the second end connected to air compressor with pressured air (Figure 1, para. 2.2). Ye teaches that the pump is connected to the nozzle with tubes and that the droplets were dropped into a beaker (para. 2.2 first section). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the system taught by Zhang by connecting the second end of the tube to a compressor with pressured air, as suggested by Ye. One of ordinary skill in the art would be motivated to do so in order to control the diameter of the droplets. Since Zhang and Ye both teach a desire to form alginate droplets, there is a reasonable expectation of success. Zhang teaches the alginate bead has an average diameter of 3 mm (Figure 6). Ye teaches the particles have a diameter of 500 µm (i.e., 0.5 mm) (Fig. 3). Regarding claims 21 and 37, Zhang teaches using 4 g of alginate in 200 mL water (2% alginate solution) (para. 2.2) and teaches that cryo-cross-linking was achieved at -13 °C. Zhang does not teach the pressure in the tube. However, Ye teaches pressure of 40 Kpa (i.e. 0.4 Bar) (para. 3.1.1). One of ordinary skill in the art would be motivated to use an air pressure of 0.4 Bar in order to produce particles with uniform diameter. Regarding claim 23, Zhang teaches using CaCl2 solution in a low-temperature bath and teaches that cross-linking was achieved at -13oC (page 7293 para. 2.4). Regarding claim 24, Zhang teaches that the concentration of the cross-linking CaCl2 solution is 15%. One of ordinary skill in the art would be motivated to optimize the concentration of the cross-linking reagent depending on the reagent itself and to control the speed of the cross-linking reaction. Regarding claim 39, Zhang does not teach the exact size of the pores. However, it can be estimated from Figure 7 that the diameter of the pore in the bead is bigger than 10 µm. Regarding claim 40-41, Ye teaches alginate bead with pore diameter of 150 µm (Fig. 8d). One of ordinary skill in the art would be motivated to optimize the diameter of the pores in order to form beads capable to holding biological material such as cells of different sizes. Claim 22 remains rejected under 35 U.S.C. 103 as being unpatentable over Zhang and Ye as applied to claim 20 above, and further in view of Buthe (Journal of microencapsulation 21.8 (2004): 865-876). Regarding claim 22, Zhang and Ye do not teach wherein the cooled liquid in the first beaker is a hydrophobic solvent, and wherein the hydrophobic solvent is selected from the group consisting of hexane, heptane and octane. However, Buthe teaches a method for the preparation of alginate beads with improved shape and teaches the alginate solution was dispensed into a solution of hexane (abstract, figure 1). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to further modify the system taught by Zhang by dispensing the alginate solution into a hexane solution as suggested by Buthe. One of ordinary skill in the art would be motivated to do so in order to improve the roundness of the beads. Since Zhang and Buthe teach a desire to form alginate beads, there is a reasonable expectation of success. Response to Arguments Applicant's arguments filed 01/07/2026 have been fully considered but they are not persuasive. Applicant argues that Zhang does not disclose the features associated with the various beakers. Applicant presents a figure (Remarks page 10) to show what features in Zhang might possibly be the micro-dispenser, the first beaker and the second beaker. Applicant argues the second beaker cannot be the same as the first beaker because the claim delineates between a first beaker and a second beaker and argues the second beaker house a cooled cross-linking reagent configured to receive the frozen drops from the first beaker. In response to the argument, Zhang teaches a first container housing a cooled crosslinking solution that receives the dispensed droplets (Figure 1) (i.e., a first beaker housing a cooled liquid and configured to receive dispensed droplets from the micro-dispenser). Zhang teaches the droplets in the container freeze first then crosslink (page 7293 left column first para.) (i.e. drops mix with cooled liquid to form frozen drops). Zhang teaches a second beaker housing the first beaker which contains the cooled crosslinking reagent and the frozen droplets (i.e., a second beaker housing a cooled cross-linking reagent). Zhang teaches that the second beaker contains the first beaker and thus can receive the contents of the first container including the frozen droplets (i.e., is configured to receive the frozen drops from the first beaker). Zhang teaches that the drops freeze upon mixing with the cooled solution in the first beaker and then crosslink (i.e. the frozen drops mix unthawed with the crosslinking reagent to form cross-linked drops). Scheme a), presented by Applicant and is identical to the scheme shown in the rejection, reads on the limitations of claim 20. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARY A CRUM whose telephone number is (571)272-1661. The examiner can normally be reached M-F 8:00-5:00 CT with alternate Fridays off. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, LOUISE W HUMPHREY can be reached at 571-272-5543. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MARY A CRUM/Examiner, Art Unit 1657 /THANE UNDERDAHL/Primary Examiner, Art Unit 1699
Read full office action

Prosecution Timeline

May 24, 2022
Application Filed
Sep 26, 2023
Non-Final Rejection — §103
Dec 29, 2023
Response Filed
Jan 24, 2024
Final Rejection — §103
May 20, 2024
Request for Continued Examination
May 24, 2024
Response after Non-Final Action
Sep 03, 2024
Non-Final Rejection — §103
Dec 06, 2024
Response Filed
Feb 15, 2025
Final Rejection — §103
May 21, 2025
Response after Non-Final Action
Jun 23, 2025
Request for Continued Examination
Jun 25, 2025
Response after Non-Final Action
Sep 24, 2025
Non-Final Rejection — §103
Jan 07, 2026
Response Filed
Feb 12, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12577274
MANUFACTURE OF GLUCAGON PEPTIDES
2y 5m to grant Granted Mar 17, 2026
Patent 12576115
BACTERIAL COMPOSITIONS FOR TREATING AND PREVENTING HALITOSIS
2y 5m to grant Granted Mar 17, 2026
Patent 12539319
LACTOBACILLUS DELBRUECKII SUBSP. LACTIS CKDB001 STRAIN, AND COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER COMPRISING SAME
2y 5m to grant Granted Feb 03, 2026
Patent 12508216
PROCESS FOR THE PREPARATION OF ANTIMALASSEZIA POWDER
2y 5m to grant Granted Dec 30, 2025
Patent 12508289
PROBIOTIC COMPOSITIONS FOR LONG COVID
2y 5m to grant Granted Dec 30, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
41%
Grant Probability
99%
With Interview (+68.3%)
3y 6m
Median Time to Grant
High
PTA Risk
Based on 78 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month